Clinical trial · Interventional
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma
NCT00985829CI-TRIAL-00002915completedPhase 1Results postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the efficacy of pdt in treatment of bcc and factors that affect response rate.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Basal Cell Carcinoma | Basal Cell Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| photodynamic therapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- BCC, ALA-PDT
- description
- Patients with histologically proven basal cell carcinoma who were candidates for treatment with ALA-PDT
- interventionNames
- Radiation: photodynamic therapy
Primary outcomes (1)
- measure
- Clinical Response to Photodynamic Therapy
- timeFrame
- immediately after termination of treatment course (with an average of 5 month after initiation of PDT)
- description
- categorized in 3 groups: complete response: there was no visible or palpable lesion; partial response: there was a visible or palpable lesion but the diameter of the lesion had reduced; no response: there was a visible or palpable lesion and the diameter of the lesion had not reduced
Secondary outcomes (1)
- measure
- Histologic Resolution of Lesion
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically proven BCCs Exclusion Criteria: * rodent ulcer * morphea type * ANA + * history of photosensitivity or photodermatosis or ingestion of phototoxic drugs during last month * pregnancy * breast feeding * age\< 18 * history of another therapeutic intervention for bcc during last 6 months
References
Publications (0)
Data not yet available
No reference posted for this study.